MedPath

Study to Evaluate the Efficacy of Bare Performance Nutrition's Peak Sleep Supplementation on Sleep Quality and Duration.

Not Applicable
Completed
Conditions
Sleep
Interventions
Dietary Supplement: Placebo
Dietary Supplement: Bare performance supplement
Registration Number
NCT05222919
Lead Sponsor
Bare Performance Nutrition
Brief Summary

This is a single-blinded observational randomized-control trial to study the efficacy of a dietary supplement and its effect on sleep quality, recovery, and workout performance.

Detailed Description

This is a single-blinded observational randomized-control trial to study the efficacy of a dietary supplement and its effect on sleep quality, recovery, and workout performance.

It is hypothesized that the dietary supplement "Peak Sleep" will improve sleep quality - as defined as deep sleep, REM sleep, and feeling more rested the next day, as well as promoting the performance in workouts of trial participants.

A total of 72 participants will be recruited for the trial following the screening. The trial will be fully remote, a technology platform will be utilized to screen, enroll and capture study data of the participants, and participants will either receive the "Peak Sleep" product or receive a placebo - depending on the study group they got randomized in - for eight weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
72
Inclusion Criteria
  • Male & Female between 24-45 years old
  • Self-reported mild to moderate sleep issues
  • 3+ days of physical exercise per week
  • Self-reported stressful lifestyle
  • Own a sleep tracker that can be used for the study (e.g. Oura ring, Apple Watch, FitBit, -Whoop band, or similar other devices)
  • Must be in good health (don't report any medical conditions asked in the screening questionnaire)
  • Following a stable, consistent diet regimen
  • Willing to maintain current dietary pattern, activity level, and stable body weight for the duration of the study, and refrain from any drastic lifestyle changes
Exclusion Criteria
  • Severe chronic conditions including oncological conditions, psychiatric disease, or other
  • Diagnosed insomnia
  • Food intolerances/allergies that require an EpiPen
  • Females that are pregnant, want to become pregnant for the duration of the study, or who are breastfeeding
  • Individuals that participate in another research study during the study period
  • Individuals with a history of drug, alcohol, or substance abuse
  • Individuals taking any other sleep supplements and are unwilling to stop taking those supplements for the duration of the study period
  • Individuals who have night terrors regularly
  • Individuals who regularly sleepwalk
  • Individuals who have regular bad dreams

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboPlacebo
Bare performance supplementBare performance supplementDietary supplement
Primary Outcome Measures
NameTimeMethod
Change in sleep qualityBaseline to 8 weeks

Survey-based assessment (0-5 scale with 0 being the lowest possible score and 5 being the highest) of changes in sleep quality between baseline and study intervention period.

Change in recovery time after a workoutBaseline to 8 weeks

Survey-based assessment (0-5 scale with 0 being the lowest possible score and 5 being the highest) of changes in workout recovery time between baseline and study intervention period.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Citruslabs

🇺🇸

Santa Monica, California, United States

© Copyright 2025. All Rights Reserved by MedPath